Combination antibiotic therapy

Chinese Journal of Antibiotics

Volumn 32, Issue 6, 2007, Pages 324-328

  Zheng, Bao Ying ^a   Zhang, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotic; Drug combination; Interaction

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; COLONY FORMING UNIT; DRUG INDICATION; DRUG RESEARCH; DRUG USE; MINIMUM INHIBITORY CONCENTRATION; REVIEW; THEORETICAL STUDY;

EID: 34548130205     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chinese source
5. Lin E, Stanek R J, Mufson M A. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro [J]. Antimicrob Agents Chemother, 2003,47(3):1151
6. Bonapace C R, White R L, Friedrich L V, et al. Evaluation of antibiotic synergy agaist Acinetobacter baumannii : a comparison with E-test, time-kill, and checkerboard methods [J]. Diagn Microbiol Infect Dis, 2000,38(1):43
7. Chinese source
8. Johansen H K, Jensen T G, Dessau R B, et al. Antagonism between penicillin and erythromycin in agaist Streptococcus pneumoniae in vitro and in vivo [J]. J Antimicrob Chemother, 2000,46(6):973
9. Dawis M A, Isenberg H D, France K A, et al. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms [J]. J Antimicrob Chemother, 2003,51(5):1203
10. Le T, Bayer A S. Combination antibiotic therapy for infective endocarditis [J]. Clin Infect Dis, 2003,36(5):615
11. Lewis R E, Diekema D J, Messer S A, et al. Comparison of E-test, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species [J]. J Antimicrob Chemother, 2002,49(2):345
12. Grzybowska W, Banaszczyk-Rus M, Tyski S. Comparison of checkerboard and E-test methods used for the analysis of two antibiotic combination [J]. Med Dosw Mikrobiol, 2005,57(1):65
13. Chinese source
14. Eliopoulos G M, Eliopoulous C T. Antibiotic combinations; Should they be tested? [J]. Clin Microbiol Rev, 1988,1(2):139
15. Thauvin C, Eliopoulos G M, Wennersten C, et al. Antagonistic effect of penicillin-amikacin combinations against enterococci [J]. Antimicrob Agents Chemother, 1985,28(1):78
16. Paul M, Benuri-Silbiger I, Soares-Weiser K, et al. β-lactam monotherapy versus β-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials [J]. BMJ, 2004,328(7441):668
17. Oosterheert J J, Bonten M J, Hak E, et al. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review [J]. J Antimicrob Chemother, 2003,52(4):555
18. Woodhead M. Community-acquired pneumonia guidelines-an international comparison: a view from Europe [J]. Chest, 1998,113(Suppl 3):183S
19. Martinez J A, Horcajada J P, Almela M, et al. Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia [J]. Clin Infect Dis, 2003,36(4):389
20. Gleason P P, Meehan T P, Fine J M, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia [J]. Arch Intern Med, 1999,159(21):2562
21. Chinese source
22. Martinez F J. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients [J]. Clin Infect Dis, 2004,38(Suppl 4):S328
23. Deshpande L M, Jones R N. Antagonism between penicillin and erythromycin agaist Streptococcus pneumoniae : Does it exist? [J]. Diagn Microb Infect Dis, 2003,46(3):223
24. Chinese source
25. Amsden G M. Anti-inflammatory effects of macrolidesan underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? [J]. J Antimicrob Chemother, 2005,55(1):10
26. Ortega M, Marco F, Soriano A. In vitro antagonism between β-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order? [J]. Intern J Antimicrob Agents, 2004,24(2):178
27. Chinese source
28. Chinese source
29. Gavalda J, Torres C, Tenorio C, et al. Efficacy of ampicillin plus ceftriaxone in treatment of expeimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides [J]. Antimicrob Agents Chemother, 1999,43(3):639
30. Hopefl A W. Overview of synergy with reference to double beta-lactam combinations [J]. Annal Pharmacother, 1991,25(9):972